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This issue of CLINICS which appears as CLINICS:
REVIEWS opens a new collection of supplements to be
published at a frequency of 1-3 per year. Each supplement
will be dedicated to a specific medical chapter. This first
issue is dedicated to Neurological and Behavioral Sciences.
We believe we have been extremely fortunate in the authors
who accepted to cooperate with this new development.
From the Medical Research Council, UK and the
Massachusetts Institute of Technology, USA, Timothy
Bliss and Sam Cooke have provided us with a highly
intriguing discussion on the clinical repercussions of the
memory fixation and deletion properties of long-term
potentiation and depression. In addition to their physiolo-
gical relevance, long-term potentiation and depression may
have important clinical applications. Molecular mechanisms
underlying these processes, and technological advances in
non-invasive manipulation of brain activity, now puts us at
the threshold of harnessing long-term potentiation and
depression, as well as other forms of synaptic, cellular and
circuit plasticity to manipulate synaptic strength in the
human nervous system. These approaches hold promise for
the treatment of a variety of neurological conditions,
including neuropathic pain, epilepsy, depression, amblyo-
pia, tinnitus and stroke.
From the Department of Psychiatry of Sa ˜oP a u l oU n i v e r s i t y
Medical College, Luiz Ferreira and Geraldo Busatto review
the very current theme of early diagnosis of Alzheimer’s
disease. Neuroimaging techniques have provided invaluable
information about Alzheimers disease. Due to recent
advances, these methods will have an increasingly important
role in research and clinical practice. It is now a well-
established fact that therapeutic strategies will focus on early
diagnosis and attempts to retard and ultimately prevent
disease evolution. Recent neuroimaging studies of Alzheimers
diseasehaveprovidedrelevantinformationtoclinicalpractice.
A new diagnostic modality, i.e. in vivo amyloid imagingis
proving to be a valuable addition to the more established
procedures of magnetic resonance, single photon emission
computed tomography(SPECT) and 18F-fluorodeoxyglucose-
positron emission tomography (FDG-PET).
From the Department of Neurology of Duke University the
Research Group headed by Miguel Nicolelis provides us
with a review on future developments in brain machine
interface research by Mikhai Lebedev et al. Neuroprosthetic
devices based on brain-machine interface technology hold
promise for the restoration of body mobility in patients
suffering from devastating motor deficits caused by brain
injury, neurological diseases and limb loss. Progress has been
recently achieved in this multidisciplinary research, mainly
in brain-machine interactors that enact upper-limb function-
ality, but many problems need to be resolved before fully
functional limb neuroprostheses can be built. This paper
reviews future stepsthat arepart ofthestrategicplanofDuke
University and its partners to bring this new technology to
clinical fruition.
Suely Marie and Sueli Shinjo, from the Department of
Neurology of Sa ˜o Paulo University Medical College brings
us new insights into the interaction of cellular energy
metabolism and brain cancer, in which they review current
literature and present original new data. A crucial point
made here is that to support rapid proliferation, cancer cells
select glycolysis in the presence of oxygen (Warburg effect)
to fuel macromolecules for the synthesis of nucleotides, fatty
acids, and aminoacids for the accelerated mitosis, rather
than fuel the tricarboxylic acid cycle and oxidative
phosphorylation. Metabolic pathways are modified by
cancer cells and the interactions between oncogenes and
tumor suppressor genes with these pathways may enlighten
new strategies for cancer therapy. Potential therapeutic
targets of the cancer energetic metabolism are enumerated,
highlighting the astrocytomas, the most common brain
cancer.
The pathophysiology of Alzheimer’s disease is discussed
from the same Department of Psychiatry of Sa ˜o Paulo
University by Evelin L. Schaeffer, Micheli Figueiro ´ and
Wagner F. Gattaz who describe the main transgenic mouse
models of Alzheimer’s disease which have been adopted in
Alzheimer’s research, and discuss the insights into its
pathogenesis from studies in such models. These have been
key to the understanding of the roles of soluble b-
amiloidoligomers in disease pathogenesis, as well as of the
relationship between pathologies relating b-amiloidplaques
or to neurofibrillary tangles containing hyperphosphory-
lated Tau protein.
Carla Scorza and Esper Cavalheiro from the Department
of Neurology of the Federal University of Sa ˜o Paulo review
the significant theme of translational research relating to
animal models of animal intelligence disabilities. Human
intellectual disability affects 2-3% of the general population,
making it a daunting, but poorly understood social problem
characterized by limitations in intellectual functioning and
in adaptive behavior. Studies in humans have a very limited
capacity to explain basic mechanisms of this condition,
making animal models an invaluable investigative tool.
Translational research specifically aims at taking basic
scientific discoveries and best practices to benefit the lives
of people and this review describes animal models of
potential risk factors for intellectual disabilities.
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1From the same Department, Fulvio Scorza et al. review a
much neglected issue: sudden unexpected death in
epilepsy. This is one of the most common neurologic
problems worldwide. Unfortunately, individuals with epi-
lepsy are at higher risk of death than the general population,
and sudden unexpected death in epilepsy is the most
important direct epilepsy-related cause of death. This article
focuses on the risk factors, mechanisms and preventative
measures obtained from clinical and experimental studies
on sudden unexpected death in epilepsy.
Peyman Yeganeh-Doost et al., from the Departments of
Psychiatry, University of Go ¨ttingen and University of Sa ˜o
Paulo provide us with a provoking review on the role of the
cerebellum in schizophrenia. The cerebellum is involved in
cognitive functions such as attention, working memory,
verbal learning and sensory discrimination. In schizophre-
nia, a disturbed prefronto-thalamo-cerebellar circuit has
been proposed to play a role in the pathophysiology. A
deficit of the glutamatergic NMDA receptor has been
hypothezised. The risk gene neuregulin 1 (NRG-1) may
play major role in this process. Altered expressions of
receptors in right cerebellar regions of schizophrenia
patients, which may be secondary upregulations due to
dysfunctional receptor has been shown. A dysfunction of
the gamma amino butyric system may also be involved.
Molecular findings in the light of the role of the cerebellum
in attention and cognitive deficits in schizophrenia are
discussed.
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